Presidio Management Group X LLC - Aug 1, 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc. (EFTR)

Role
10%+ Owner
Signature
Dale Holladay, Attorney in Fact for each Reporting Person
Stock symbol
EFTR
Transactions as of
Aug 1, 2022
Transactions value $
-$91,203
Form type
4
Date filed
8/3/2022, 05:58 PM
Previous filing
Jul 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Sale -$20.4K -25.9K -0.63% $0.79 4.07M Aug 1, 2022 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$634 -807 -0.62% $0.79 130K Aug 1, 2022 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$21.8K -27.3K -0.67% $0.80 4.04M Aug 2, 2022 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$680 -853 -0.66% $0.80 129K Aug 2, 2022 Directly owned by AFF X F1, F2
transaction EFTR Common Stock Sale -$46.3K -57.6K -1.43% $0.80 3.98M Aug 3, 2022 Directly owned by USVP X F1, F2
transaction EFTR Common Stock Sale -$1.44K -1.8K -1.39% $0.80 128K Aug 3, 2022 Directly owned by AFF X F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Presidio Management Group X LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2 Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.